These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2038795)

  • 1. Resolution of hepatic metastases from carcinoma of prostate with stilbestrol.
    Blyth B; McRae CU; Turner JG
    Urology; 1991 Jun; 37(6):574-5. PubMed ID: 2038795
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoma associated with diethylstilbestrol therapy for prostatic carcinoma.
    Brooks JJ
    J Urol; 1982 Nov; 128(5):1044-5. PubMed ID: 6294349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diethylstilbestrol-induced liver cancer?].
    Rosinus V; Maurer R
    Schweiz Med Wochenschr; 1981 Jul; 111(30):1139-42. PubMed ID: 6267685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
    Endo H; Murakami T; Nishimoto I; Sekine I; Yokoyama M
    Acta Pathol Jpn; 1987 May; 37(5):795-806. PubMed ID: 2442958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinoma: treatment of liver metastases with intravenous diethylstilbestrol diphosphate.
    Jacobo E; Flocks RH; Culp DA
    Urology; 1975 Sep; 6(3):351-3. PubMed ID: 1162814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The question of stilbestrol in the treatment of prostatic carcinoma.
    Lawrence W; Horsley JS
    Va Med Mon (1918); 1968 Apr; 95(4):238-40. PubMed ID: 5645075
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilateral breast metastases from oat-cell lung carcinoma in a man treated with diethylstilbestrol for prostatic adenocarcinoma.
    Giarelli L; Ferlito A
    J Am Geriatr Soc; 1976 Nov; 24(11):511-5. PubMed ID: 184140
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen-induced porphyria cutanea tarda complicating treatment of prostatic carcinoma.
    Weimar VM; Weimar GW; Ceilley RI
    J Urol; 1978 Nov; 120(5):643-4. PubMed ID: 712918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diethyl-stilbestrol for treatment of prostatic carcinoma].
    Cifuentes Delatte L
    Arch Esp Urol; 1990 Sep; 43(7):697-704. PubMed ID: 2125823
    [No Abstract]   [Full Text] [Related]  

  • 12. Obstructive jaundice associated with carcinoma of the prostate.
    Ben-Ishay D; Slavin S; Levij IS; Eliakim M
    Isr J Med Sci; 1975 Aug; 11(8):838-44. PubMed ID: 1165179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketoconazole therapy for hormonally refractive metastatic prostate cancer.
    Johnson DE; Babaian RJ; von Eschenbach AC; Wishnow KI; Tenney D
    Urology; 1988 Feb; 31(2):132-4. PubMed ID: 3341098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosquamous carcinoma of the prostate: a case report.
    Devaney DM; Dorman A; Leader M
    Hum Pathol; 1991 Oct; 22(10):1046-50. PubMed ID: 1842377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC; Gill GM; Cummings KB
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver and prostate adenocarcinoma: an "estrogen-free" environment?
    Guice SL; Glenn JF; Paulson DF
    Urology; 1978 Feb; 11(2):175-8. PubMed ID: 628997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of treatment with diethylstilbestrol for carcinoma of prostate on platelet aggregation and plasma lipoproteins.
    Agardh CD; Rasmussen F; Nilsson-Ehle P; Gustafson A
    Urology; 1986 Dec; 28(6):469-71. PubMed ID: 3787919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.